Camber Spine grew its sales 22 percent in the first quarter of 2019, according to recently released unaudited sales figures.
What you should know:
1. Camber Spine attributed the growth to its Spira and Enza technology platforms.
2. Spira and Enza sales grew 94 percent from the same period last year.
3. Utilization rates are also up. Camber increased its surgeon user rate 37 percent year over year.
4. Camber plans to launch lateral and anterior to psoas-specific implants and receive a CE certification mark for Spira sometime in 2019, which will indicate its compliance with certain European health, safety and environmental standards.